FELLOWSHIPS AND RESEARCH GRANTS ANNOUNCEMENT
ACADEMIC YEAR 2010-2011

The American Parkinson Disease Association Inc. has not budgeted research funds to be awarded during the 2010-2011 and following academic years.

The American Parkinson Disease Association will be accepting new applications for the Medical Student Summer Fellowships for 2010. Applications are to be submitted electronically by January 31, 2010.

The American Parkinson Disease Association will not be accepting applications for Research Grants, Postdoctoral Fellowships, the Cotzias Memorial Fellowships, the Roger Duvoisin Research Grant and Centers for Advanced Research for fiscal year 2010-2011.

You may contact Michele Popadynec, RN, MPS at 800 223-2732 ext. 118 or via email at www.mpopadynec@apdaparkinson.org for more information.

Medical Students Summer Fellowships

The APDA Summer Fellowships are designed to provide a stipend to enable medical students to perform supervised laboratory or clinical research designed to clarify our understanding of Parkinson’s disease, its nature, manifestations, etiology or treatment. It is hoped this experience will stimulate a student’s interest in future research in the field of Parkinson’s disease and related disorders.This is a Fellowship of $4,000 for a three(3) month summer commitment.

DeadLine

1/31/2010   Details

Fellowship/Research Grant Application


APDA Research Funding Fiscal Year 2008 - 2009

George C. Cotzias, MD Memorial Fellowships

Talene Yacoubian, MD, Ph.D.
The University of Alabama
Birmingham, Al

Role of 14-3-3 Proteins in Alpha Synuclein Induced Neurotoxicity

 

David Hinkle, MD, Ph.D.
University of Pittsburgh
Pittsburg, PA

The Potential Role of Antioxidant Systems in the Mechanism of DJ-1 Dependent Astrocytemediated Neuroprotection

 

Bradley Miller, MD, Ph.D.
University of Virginia
Charlottesville, VA

Distribution and Metabolic Consequences of Mitochondrial DNA Deletions in Substantia Nigra and Cultured Cells

 

Roger C. Duvoisin, MD, Research Grant

Andrei Alexandrescu, Ph.D.
University of Connecticut
Storrs, CT

Stability and Solvent Accessibility of Alpha-Synuclein Fibrils by NMR Hydrogen Exchange

 

Marc Tatar, Ph.D.
Brown University
Providence, RI

Assessing the Pathogenic and Molecular Consequences of FOXO Regulation by Parkin

 

Jeffrey Stock, Ph.D.
Princeton University
Princeton, NJ

Protein Phosphatase 2A Methylation as a Therapeutic Target for Parkinson’s Disease

 

Research Grants

Matthew Goldberg, Ph.D.
UT Southwestern Medical Center
Dallas, TX

Parkin, DJ-1 and Glutathione Peroxidase-Deficient Mouse Models of PD

 

Jean Rochet, Ph.D.
Purdue University
West Lafayette, IN

Role of ATP13A2 (PARK9) Dysfunction in Parkinson’s Disease

 

Hardy Rideout, Ph.D.
Columbia University
New York, NY

Modification of LRRK2 Oligomerization and Neurodegeneration by 14-3-3

 

Arnulfo Quesada, Ph.D.
Brentwood Biomedical Research Institute
Los Angeles, CA

A Promising New Protective Factor for Parkinson’s Disease

 

Anthony Nicholas, MD, Ph.D.
University of Alabama
Birmingham, AL

Gene Analysis of Histone Deacetylation in Levodopa-Induced Dyskinesia and Priming

 

Darren Moore, Ph.D.
Johns Hopkins University
Baltimore, MD

Dopamine Neuron-Specific Accumulation of Mitochondrial DNA Mutations in Mice

 

Subhojit Roy, Ph.D.
University of California
Jolla, CA

Effects of Alpha-Synuclein on Fast and Slow Axonal Transport

 

Steven Johnson, MD, Ph.D.
Portland VA Research
Portland, OR

Redox Regulation of NMDA Currents in Midbrain Dopamine Neurons

 

Jian Feng, Ph.D.
State University of New York
Buffalo, NY

Generating Patient –Specific Induced Pluripotent Stem Cells to Study Parkinson’s Disease

 

Wei Ming Duan, MD, Ph.D.
Louisiana State University
Shreveport, LA

Generation of Dopaminergic Neurons from Endogenous Stem Cells in the Brain of a Mouse Model of Parkinson’s Disease

 

Paul Davenport, Ph.D.
University of Florida
Gainesville, FL

Central Neural Gating of Pharyngeal Mechanically Elicited Cortical Evoked Potentials (CEP): An Evaluation of Swallow Neural Integration in Parkinson’s Disease (PD)

 

Shankar Chinta, Ph.D.
Buck Institute for Age Research
Novato, CA

Potential Neuroprotective Role of Resveratrol in Parkinson’s Disease Mouse Models

 

Shu Chen, Ph.D.
Case Western Reserve University
Cleveland, OH

Transgenic C. Elegans Model of LRRK2-Linked Parkinson Disease

 

Linan Chen, MD, Ph.D.
University of Chicago
Chicago, IL

Transgenic Overexpression Selectively in Dopamine Neurons via Controlled Genetic Amplification

 

Savio Chan, Ph.D.
Northwestern University
Chicago, IL

Sriatopallidal GABAergic Signaling in Mouse Models of Parkinson’s Disease

 

Ippolita Castelvetri, Ph.D.
Massachusetts General Hospital
Charlestown, MA

Biological Basis for Diferential Susceptibility to Alpha-Synuclein Pathology in the Male and Femal Human Brain

 

Hans Bueler, Ph.D.
University of Kentucky
Lexington, KY

Identification of PINK1 Substrates Using Conditional PINK1 Knockout Cells and Quantitative Phosphoproteomics

 

Shubhik Kumar, Ph.D.
Lake Forest College
Lake Forest, IL

A Study of Autophagic Regulation of Alpha-Synuclein Toxicity in Yeast

 

Jianhui Zhu, Ph.D.
University of Pittsburgh
Pittsburgh, PA

ATP13A2 and Autolysosomal Pathology in Parkinson’s Disease

 

Derek Siebruth, Ph.D.
University of Southern California
Los Angeles, CA

Large Scale Analysis of Synaptic Architecture in Alphasynuclein Expressing Neurons

 

Gaofeng Wang, Ph.D.
University of Miami
Coral Gables, FL

The Role of miRNA in Olfactory Deficit of Parkinson’s Disease

 

Andrew West, Ph.D.
University of Alabama
Birmingham, AL

Development of Cell Based Kinase Assays for LRRK2

 

Gerardo Morfini, Ph.D.
University of Illinois
Chicago, IL

Molecular Mechanisms Underlying MPP+ Induced Activation of Cytoplamic Dynein-Based Vesicle Transport

 

Fu-Ming Zhou, MD, Ph.D.
University of Tennessee
Memphis, TN

An Ultra Short Dopamine Pathway: Part II. Signaling Mechanisms

 

Xiongwei Zhu, Ph.D.
Case Western Reserve University
Cleveland, OH

Role of Impaired Mitochondrial Dynamics in Mutant LRRK2 Induced Toxicity

 

Harrison Walker, MD
University of Alabama
Birmingham, AL

Bilateral Clinical and Neurophysiological Effects of Unilateral STN DBS in PD

 

 

Kala Venkiteswaran, Ph.D.
Penn State Hershey College of Medicine
Hershey, PA

Transplantation of Transdifferentiated Dopaminergic Neurons Derived from Human Retinal Pigment Epithelial Cells

 

Enrique Torre, Ph.D.
Emory University
Atlanta, GA

Significance of mRNA Transport and Translation within the Dopaminergic Axon

 

Shaji Theodore, Ph.D.
University of Alabama
Birmingham, AL

Inhibiting Nuclear Factor Kappa B Signaling and Microglial Activation in a Mouse Model of Parkinson’s Disease

 

Wanli Smith, MD, Ph.D.
Johns Hopkins University School of Med.
Baltimore, MD

Autophagy and LRRK2-Linked Parkinsonism

 

Kui Xu, MD, Ph.D.
Massachusetts General Hospital
Boston, MA

Neuroprotection by Urate in Cellular Models of Parkinson’ s Disease

 

Post-Doctoral Fellowships

Gizem Donmez, Ph.D.
Massachusetts Institute of Technology
Cambridge, MA

Analysis of the Role of SIRT2 Protein in Parkinson’s Disease

 

Nanyan Zhang, Ph.D.
University of Colorado
Aurora, CO

Delineating Protein Coaggregation during Lewy Body Formation

 

Yulan Xiong, Ph.D.
Johns Hopkins University
Baltimore, MD

Modeling LRRK2-Induced Toxicity in Yeast

 

Ravindar Thomas, Ph.D.
University of Virginia
Charlottesville, VA

Development of Mitochondrial Gene Therapy for Parkinson’s Disease

 

Jason Cannon, Ph.D.
University of Pittsburgh
Pittsburgh, PA

Genetic and Environmental Interactions in Parkinson’s Disease: Potential for New Therapeutic Pathways

 

William Caudle, Ph.D.
University of Washington
Seattle, WA

Proteomic Analysis of VMAT2 under Normal and Pathological Conditions

 

Robert Drolet, Ph.D.
University of Pittsburgh
Pittsburgh, PA

Gastrointestinal Dysfunction in the Rotenone Model of Parkinson’s Disease

 

Muralidhar Hedge, Ph.D.
Uiversity of Texas
Galveston, TX

Role of Transition Metals in Inhibiting Repair of Oxidized Bases in Genome: Relevance to Parkinson’s Disease

 

William Lin, Ph.D.
University of Chicago
Chicago, IL

Mechanism and Function of Cytosolic PINK1

 

Zhihui Sun, Ph.D.
University of Pennsylvania
Philadelphia, PA

Investigating Synuclein Gene FunctionIn Zebrafish

 

Stephen Crimmins, Ph.D.
University of Alabama
Birmingham, AL

Reduction of Alpha-Synuclein and Neuroprotection Against its Toxicity by Enhancing Proteasome Activities

 

Yeun Su Choo, Ph.D.
Burnham Institute for Medical Research
La Jolla, CA

Regulation of Parkin by Neddylation

 

Daniel Tardiff, Ph.D.
Whitehead Institute for Biomedical Res.
Cambridge, MA

Mitochondrial Proteomics of a Yeast Parkinson’s Disease Model

 

Medical Students Summer Fellowships

Ephraim Church

University of Pennsylvania
Philadelphia, PA

 

Neena Marupudi

Penn State College of Medicine
Hershey, PA

 

Omar Atassi

Johns Hopkins University
Baltimore, MD

 

Anthony Burrows

University of Massachusetts Med. School
Worcester, MA

 

Jennifer Kosty

University of Pennsylvania
Philadelphia, PA

 

Jennifer O’Malley

University of Cincinnati
Cincinnati, OH

 

Centers for Advanced Research

The University of Chicago
Chicago, IL

Boston University School of Medicine
Marie St. Hilaire, MD
Boston, MA

 

Emory University School of Medicine
Mahlon DeLong, MD
Atlanta, GA

University of Virginia Medical Center
Frederick G. Wooten, MD
Charlottesville, VA

 

UCLA School of Medicine
Marie Francois Chessiet, MD, PhD
Los Angeles, CA

Washington University Medical Center
Joel Perlmutter, MD
St. Louis, MO

 

University of Pittsburgh
J. Timothy Greenamyre, MD, PhD
Pittsburgh, PA

 

University of Alabama
David Standaet, MD
Birmingham, AL

Robert Wood Johnson Medical School
Jacob Sage, MD
New Brunswick, NJ